Document ID: chunk:federal_register_of_legislation:F2021L01332:reg:16:p2
Version: federal_register_of_legislation:F2021L01332
Segment Type: reg
Provision Reference: reg 16 (pt 2/2)
Character Range: 22840–24209

provides storage and transportation requirements in relation to human cardiovascular tissue products that are subjected to only minimal manipulation and are manufactured for allogeneic use only. However, subsection (4) applies in relation to all other human cardiovascular tissue products.
Note 3: Part 5 provides storage and transportation requirements in relation to human ocular tissue products that are subjected to only minimal manipulation and are manufactured for allogeneic use only. However, subsection (4) applies in relation to all other human ocular tissue products.
Note 4: Part 6 provides storage and transportation requirements in relation to human skin products that are subjected to only minimal manipulation. However, subsection (4) applies in relation to all other human skin products.
Note 5: Part 7 provides storage and transportation requirements in relation to human amnion products that are subjected to only minimal manipulation. However, subsection (4) applies in relation to all other human amnion products.
 (6) A biological that is returned to its manufacturer cannot be released for supply unless:
 (a) the biological was at all times stored and transported in accordance with applicable storage and transportation requirements in relation to the biological; and
 (b) the labelling and packaging of the biological has not been compromised.